These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10216150)

  • 1. Diagnosis of hepatic encephalopathy: will in vivo proton MRS play a role?
    Jalan R; Olde Damink SW; Hayes PC; Wardlaw JM
    Hepatology; 1999 May; 29(5):1605-7. PubMed ID: 10216150
    [No Abstract]   [Full Text] [Related]  

  • 2. Magnetic resonance imaging and localized in vivo proton spectroscopy in patients with fulminant hepatic failure.
    Gupta RK; Saraswat VA; Poptani H; Dhiman RK; Kohli A; Gujral RB; Naik SR
    Am J Gastroenterol; 1993 May; 88(5):670-4. PubMed ID: 8480729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noncirrhotic portal vein thrombosis exhibits neuropsychological and MR changes consistent with minimal hepatic encephalopathy.
    Mínguez B; García-Pagán JC; Bosch J; Turnes J; Alonso J; Rovira A; Córdoba J
    Hepatology; 2006 Apr; 43(4):707-14. PubMed ID: 16557541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lactulose in the treatment of chronic hepatic encephalopathy: report of three cases.
    Juttijudata P; Meensook C
    J Med Assoc Thai; 1981 Dec; 64(12):636-9. PubMed ID: 6153032
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hepatic encephalopathy].
    Maruyama K; Shirakura K
    Ryoikibetsu Shokogun Shirizu; 2003; (40):466-70. PubMed ID: 14626162
    [No Abstract]   [Full Text] [Related]  

  • 6. MR and 1H MR spectroscopy of the brain in patients with liver cirrhosis and early stages of hepatic encephalopathy.
    Tarasów E; Panasiuk A; Siergiejczyk L; Orzechowska-Bobkiewicz A; Lewszuk A; Walecki J; Prokopowicz D
    Hepatogastroenterology; 2003; 50(54):2149-53. PubMed ID: 14696484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Detection of subclinical and overt hepatic encephalopathy and treatment control after L-ornithine-L-aspartate medication by magnetic resonance spectroscopy ((1)H-MRS)].
    Hass HG; Nägele T; Seeger U; Hösl F; Gregor M; Kaiser S
    Z Gastroenterol; 2005 Apr; 43(4):373-8. PubMed ID: 15830303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative study of lactulose and neomycin in the treatment of porto-systemic encephalopathy].
    Sala Felis T; Berenguer J; Barrios JM; Gómez J
    Rev Esp Enferm Apar Dig; 1974 Feb; 42(3):335-42. PubMed ID: 4829021
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatic encephalopathy.
    Fraser CL; Arieff AI
    N Engl J Med; 1985 Oct; 313(14):865-73. PubMed ID: 2993889
    [No Abstract]   [Full Text] [Related]  

  • 10. A possible case of minimal hepatic encephalopathy treated successfully with lactulose.
    Spiegel DR; Surkin K
    J Neuropsychiatry Clin Neurosci; 2011; 23(1):E1. PubMed ID: 21304108
    [No Abstract]   [Full Text] [Related]  

  • 11. In vivo 1H magnetic resonance spectroscopy-derived metabolite variations between acute-on-chronic liver failure and acute liver failure.
    Verma A; Saraswat VA; Radha Krishna Y; Nath K; Thomas MA; Gupta RK
    Liver Int; 2008 Sep; 28(8):1095-103. PubMed ID: 18266634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chronic liver diseases. Hepatic encephalopathy too frequently overlooked?].
    MMW Fortschr Med; 2000 Jun; 142(25):56-7. PubMed ID: 10920673
    [No Abstract]   [Full Text] [Related]  

  • 13. Is hyperammonemia really the true cause of altered neuropsychology, brain MR spectroscopy and magnetization transfer after an oral amino acid load in cirrhosis?
    Riggio O; Efrati C; Masini A; Angeloni S; Merli M
    Hepatology; 2003 Sep; 38(3):777; author reply 778. PubMed ID: 12939607
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of hepatic encephalopathy with lactulose].
    Veljkov N; Kulenović S; Borovac N; Rezaković D
    Med Arh; 1981; 35(5-6):267-9. PubMed ID: 7345270
    [No Abstract]   [Full Text] [Related]  

  • 15. [Lactulose in treatment of hepatic encephalopathy in patient with liver cirrhosis].
    Shuliat'ev IS; Il'chenko LIu; Vinnitskaia EV; Petrakov AV; Sil'verstrova SIu
    Eksp Klin Gastroenterol; 2002; (5):38-41, 127. PubMed ID: 12619575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful use of vancomycin hydrochloride in the treatment of lactulose-resistant chronic hepatic encephalopathy.
    Tarao K; Ikeda T; Hayashi K; Sakurai A
    J Gastroenterol Hepatol; 1989; 4 Suppl 1():284-6. PubMed ID: 2519078
    [No Abstract]   [Full Text] [Related]  

  • 17. [The response to combined therapy of hepatic encephalopathy in patients with hepatic cirrhosis].
    Maev IV; V'iuchnova ES; Lebedeva EG; Iakovenko EI; Dicheva DT
    Klin Med (Mosk); 2002; 80(5):42-5. PubMed ID: 12087887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic encephalopathy.
    Córdoba J; Mínguez B
    Semin Liver Dis; 2008 Feb; 28(1):70-80. PubMed ID: 18293278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lactulose (Bifiteral)--a physiologically active intestinal agent for constipation, Salmonella and hepatic encephalopathy].
    Fortschr Med; 1982 Nov; 100(44):2059-60. PubMed ID: 7173786
    [No Abstract]   [Full Text] [Related]  

  • 20. [Lactulose and portocaval encephalopathy: value of its administration by rectal route].
    Chevrel B
    Med Chir Dig; 1977; 6(5):309-12. PubMed ID: 916764
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.